APBA2BP
From Wikipedia, the free encyclopedia
|
Amyloid beta (A4) precursor protein-binding, family A, member 2 binding protein
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | APBA2BP; NIP1; EFCBP3; NECAB3; SYTIP2; XB51; dJ63M2.4; dJ63M2.5 | |||||||||||||
| External IDs | MGI: 1861721 HomoloGene: 10992 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 63941 | 56846 | ||||||||||||
| Ensembl | ENSG00000125967 | ENSMUSG00000027489 | ||||||||||||
| Uniprot | Q96P71 | Q9D6J4 | ||||||||||||
| Refseq | NM_031231 (mRNA) NP_112508 (protein) |
NM_021546 (mRNA) NP_067521 (protein) |
||||||||||||
| Location | Chr 20: 31.71 - 31.73 Mb | Chr 2: 154.24 - 154.25 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Amyloid beta (A4) precursor protein-binding, family A, member 2 binding protein, also known as APBA2BP, is a human gene.[1]
The protein encoded by this gene interacts with the amino-terminal domain of the neuron-specific X11-like protein (X11L), inhibits the association of X11L with amyloid precursor protein through a non-competitive mechanism, and abolishes the suppression of beta-amyloid production by X11L. This protein, together with X11L, may play an important role in the regulatory system of amyloid precursor protein metabolism and beta-amyloid generation. This gene consists of at least 13 exons and its alternative splicing generates at least 2 transcript variants.[1]
[edit] References
[edit] Further reading
- Büssow K, Cahill D, Nietfeld W, et al. (1998). "A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library.". Nucleic Acids Res. 26 (21): 5007–8. PMID 9776767.
- Sugita S, Südhof TC (2000). "Specificity of Ca2+-dependent protein interactions mediated by the C2A domains of synaptotagmins.". Biochemistry 39 (11): 2940–9. PMID 10715114.
- Lee DS, Tomita S, Kirino Y, Suzuki T (2000). "Regulation of X11L-dependent amyloid precursor protein metabolism by XB51, a novel X11L-binding protein.". J. Biol. Chem. 275 (30): 23134–8. doi:. PMID 10833507.
- Deloukas P, Matthews LH, Ashurst J, et al. (2002). "The DNA sequence and comparative analysis of human chromosome 20.". Nature 414 (6866): 865–71. doi:. PMID 11780052.
- Sugita S, Ho A, Südhof TC (2002). "NECABs: a family of neuronal Ca(2+)-binding proteins with an unusual domain structure and a restricted expression pattern.". Neuroscience 112 (1): 51–63. PMID 12044471.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Sumioka A, Imoto S, Martins RN, et al. (2003). "XB51 isoforms mediate Alzheimer's beta-amyloid peptide production by X11L (X11-like protein)-dependent and -independent mechanisms.". Biochem. J. 374 (Pt 1): 261–8. doi:. PMID 12780348.
- Yoo JC, Chang JR, Kim SH, et al. (2004). "NIP1/XB51/NECAB3 is a potential substrate of Nek2, suggesting specific roles of Nek2 in Golgi.". Exp. Cell Res. 292 (2): 393–402. PMID 14697346.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:. PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:. PMID 15489334.

